The challenge of irritable bowel syndrome in primary care

26 September 2014

Pali Hugin
Professor Pali Hungin

Primary care physicians use a range of approaches to manage irritable bowel syndrome (IBS) in primary care, reports a systematic review co-authored by the Rome Foundation and researchers from Oxford PharmaGenesis. The article, which appeared online in Alimentary Pharmacology & Therapeutics this month, shows that primary care physicians are often comfortable diagnosing and managing IBS without specialist diagnostic tests or referral to a gastroenterologist. Continue reading

Scientists flock to London career event

24 September 2014

On Friday 19 September 2014 a bunch of friendly Oxford PharmaGenesis faces made the journey to London to attend The Naturejobs Career Expo 2014, which was held at the Business Design Centre. It was a very successful event and the team met some fantastic candidates. Continue reading

Exclusive Interview with Dr Jonathan Morton, Oxford PharmaGenesis Ltd, Speaking at The World Orphan Drug Congress

18 September 2014

Jon Morton
Dr Jonathan Morton (Communications Director, Rare and Orphan Diseases Practice at Oxford PharmaGenesis Ltd)

Dr Jonathan Morton, Communications Director of our Rare and Orphan Diseases Practice, will be speaking at the World Orphan Drug Congress in November. In the interview below, he provides an insight into the upcoming panel discussion at this congress, as well what he hopes to achieve in order to improve standards of care for patients with rare and orphan diseases. Dr Morton’s panel, “A problem shared … how can multi-stakeholder collaboration facilitate patient access initiatives?”, will include participants from the MPS Society, PPi Ltd and PTC Therapeutics. Continue reading

Richard White cycles from Oxford to Cambridge for the British Heart Foundation

12 September 2014

4Following on from his ALS Ice Bucket Challenge, Oxford PharmaGenesis Commercial Director Dr Richard White will be taking part in the Oxford to Cambridge bike ride on Saturday 27 September to raise money for the British Heart Foundation.

“Unfortunately, cardiovascular disease runs in my family,” said Richard, who took up road cycling last year in order to keep fit. “It is a terrible thing, as much when it brings life to a sudden end (as happened to my Aunty Betty and my Uncle Doug) as when it leads to incapacitation of previously active and healthy people (my grandmother). Pharmaceutical companies and public health initiatives have made amazing progress in reducing the incidence of heart attack and stroke. Continue reading